MTOR and cancer: Importantly, recent studies have revealed that high levels of TRIM44 induce the epithelial-to-mesenchymal transition (EMT) in cancer cells and that TRIM44 promotes tumor initiation and progression by activating the PI3K/AKT/mTOR pathway [10, 12].